Here are relevant reports on : molecular-diagnostics-market
-
Veterinary Infectious Disease Diagnostics Market by Product (Consumables, Instruments), Technology (Molecular Diagnostic, PCR, ELISA, Immunodiagnostics, Rapid Tests), Animal Type (Companion Animal, Livestock), End User & Region - Global Forecast to 2030
The global veterinary infectious disease diagnostics market, valued at US$2.66 billion in 2024, stood at US$2.87 billion in 2025 and is projected to advance at a resilient CAGR of 8.0% from 2025 to 2030, culminating in a forecasted valuation of US$4.22 billion by the end of the period.
- Published: July 2025
- Price: $ 4950
- TOC Available:
-
Veterinary Reference Laboratory Market by Service (Microbiology, Immunodiagnostics, Molecular Diagnostics, PCR, ELISA, Hematology, Urinalysis), Animal (Companion, Livestock), Application (Clinical Pathology, Toxicology), Region - Global Forecast to 2030
The global veterinary reference laboratory market, valued at US$4.48 billion in 2024, stood at US$4.75 billion in 2025 and is projected to advance at a resilient CAGR of 6.3% from 2024 to 2030, culminating in a forecasted valuation of US$6.45 billion by the end of the period.
- Published: November 2025
- Price: $ 4950
- TOC Available:
-
RSV Diagnostics Market by Product (Kits and Assays, Instruments), Method (Rapid Antigen Detection Test (Immunofluorescence Assay, ELISA), Molecular Diagnostic), End User (Hospitals & Clinics, Clinical Laboratories, Homecare) & Region
The global RSV diagnostics market is expected to grow at a CAGR of 10.1%. Market growth is primarily driven by the rising burden of RSV infections, growing demand for PoC molecular diagnostic tests for the diagnosis of RSV infections, and increasing approval of RSV diagnostic kits and assays. Key players in the RSV diagnostics market include bioMérieux (France), Becton Dickinson (US), Abbott (US), Roche (Switzerland), Danaher (US), Luminex (US), BioCartis (Belgium), Hologic (US), and Fast Track Diagnostics (Luxembourg).
- Published: February 2018
- Price: $ 4950
- TOC Available:
-
Molecular Quality Controls Market Product (Independent Control, Instrument Specific Control (PCR, DNA Sequencing), Application (Infectious Disease Diagnostics), Analyte type, End User (Hospitals, Diagnostic Lab), Region- Global Forecast to 2028
The global molecular quality controls market, valued at US$0.2 billion in 2022, stood at US$0.2 billion in 2023 and is projected to advance at a resilient CAGR of 6.6% from 2023 to 2028, culminating in a forecasted valuation of US$0.3 billion by the end of the period. The growth of this market is primarily driven by the increasing number of accredited clinical laboratories, growing adoption of third-party quality controls, and increasing government funding for genomic projects.
- Published: July 2023
- Price: $ 4950
- TOC Available:
-
Latin America Molecular Diagnostics Market by Product & Service (Kits, Instruments), Test Type (Lab, PoC), Sample (Blood, Urine), Technology (PCR, NGS, ISH), Application [Infectious (Hepatitis, HIV, HAI, Flu), Cancer (Breast, Lung)] - Forecast to 2031
The Latin America molecular diagnostics market, valued at US$0.72 billion in 2025, stood at US$0.76 billion in 2026 and is projected to advance at a resilient CAGR of 8.8% from 2026 to 2031, culminating in a forecasted valuation of US$1.16 billion by the end of the period. This growth can be attributed to the rising demand for reliable diagnostic results, especially in infectious diseases & chronic illnesses like cancer.
- Published: October 2026
- Price: $ 4950
- TOC Available:
-
Europe Molecular Diagnostics Market by Product & Service (Kits, Instruments, Software), Test Type (Lab, PoC), Sample (Blood, Urine), Technology (PCR, NGS, ISH), Application [Infectious (Hepatitis, HIV, HAI, Flu), Cancer (Breast, Lung)] - Forecast to 2031
The Europe molecular diagnostics market, valued at US$5.60 billion in 2025, stood at US$6.05 billion in 2026 and is projected to advance at a resilient CAGR of 10.9% from 2026 to 2031, culminating in a forecasted valuation of US$10.15 billion by the end of the period.
- Published: October 2026
- Price: $ 4950
- TOC Available:
-
Molecular Diagnostics Market by Product & Service (Kits, Instruments, Software), Test Type (Lab, PoC), Sample (Blood, Urine), Technology (PCR, NGS, ISH), and Application (Infectious (Hepatitis, HIV, HAI, Flu), Cancer (Breast, Lung)) - Global Forecast to 2030
The global molecular diagnostics market, valued at USD 18.29 billion in 2024, stood at USD 19.48 billion in 2025 and is projected to advance at a resilient CAGR of 9.6% from 2025 to 2030, culminating in a forecasted valuation of USD 30.74 billion by the end of the period. The Asia Pacific market is projected to register the highest CAGR during the forecast period, primarily due to the increasing healthcare expenditure and rapid expansion of medical infrastructure in Asia Pacific countries.
- Published: August 2025
- Price: $ 4950
- TOC Available:
-
US Molecular Diagnostics Market by Product & Service (Kits, Instruments, Software), Test Type (Lab, PoC), Sample (Blood, Urine), Technology (PCR, NGS, ISH), Application [Infectious (Hepatitis, HIV, HAI, Flu), Cancer (Breast, Lung)] - Forecast to 2031
The US molecular diagnostics market, valued at US$8.34 billion in 2025, stood at US$8.93 billion in 2026 and is projected to advance at a resilient CAGR of 9.9% from 2026 to 2031, culminating in a forecasted valuation of US$14.32 billion by the end of the period. The growing use of molecular tests for early diagnosis, treatment selection, and disease monitoring, along with the wider adoption of personalized medicine, is further supporting demand.
- Published: October 2026
- Price: $ 4950
- TOC Available:
-
Asia Pacific Molecular Diagnostics Market by Product & Service (Kits, Instruments), Test Type (Lab, PoC), Sample (Blood, Urine), Technology (PCR, NGS, ISH), Application [Infectious (Hepatitis, HIV, HAI, Flu), Cancer (Breast, Lung)] - Forecast to 2031
The Asia Pacific molecular diagnostics market, valued at US$3.85 billion in 2025, stood at US$4.22 billion in 2026 and is projected to advance at a resilient CAGR of 12.4% from 2026 to 2031, culminating in a forecasted valuation of US$7.58 billion by the end of the period. The Asia Pacific molecular diagnostics market is experiencing significant growth as healthcare systems across the region are increasingly focusing on enhancing the accuracy of diagnosis and increasing access to diagnostic testing.
- Published: October 2026
- Price: $ 4950
- TOC Available:
-
Point-of-Care Molecular Diagnostics Market by Product & Service (Assays, Instruments, Software), Technology (RT-PCR, INAAT), Sample Type (Blood, Urine), Application (STD, HAI, Hepatitis, Cancer), and End User (Hospitals, Clinics) - Global Forecast to 2030
The global point-of-care molecular diagnostics market, valued at US$4.01 billion in 2024, stood at US$4.30 billion in 2025 and is projected to advance at a resilient CAGR of 10.5% from 2025 to 2030, culminating in a forecasted valuation of US$7.09 billion by the end of the period. The market is experiencing strong growth due to increasing demand for timely and accessible testing solutions. A major factor is the rising prevalence of infectious diseases and cancer, which has created a growing need for fast and reliable diagnostics.
- Published: August 2025
- Price: $ 4950
- TOC Available:
Records 11 to 20 of 50
